April 8, 2016

April 08, 2016

Former PCHS football player to speak about cancer
Plant City Observer – April 8
On Tuesday, March 12, Kemp will be one of four cancer patients giving pep talks at the Moffitt Cancer Center’s “A Night of Stories to Inspire” event.

Vyxeos Increases Survival in High-Risk AML
Clinical Oncology News – April 7
“The overall survival advantage seen with CPX-351 compared with 7+3, along with a superior response rate and no increase in serious toxicity, indicates that we'll likely have a new standard of care for treating older patients with secondary AML,” principal investigator for the study Jeffrey E. Lancet, MD, the senior member and chief of the Leukemia/Myelodysplasia Program at Moffitt Cancer Center, in Tampa, Fla., said in a statement. “This represents a major step forward for a very difficult-to-treat patient population.”

Breast cancer breakthrough
WSAW – April 7
Dr. Roohi Ismail-Khan is a breast cancer specialist at Moffitt Cancer Center. She says combination therapies are standard. In fact, the same combination studied in this trial is often given to late stage HER2 patients because it’s not approved for early use.

A Bella Notte for cancer survivors and fundraising
Vero News – April 7
Neal Watkins, as master of ceremonies, kept things moving along, introducing guest speakers Storey as well as Janet Fraley, who spoke about her personal cancer story. A Vero Beach esophageal cancer survivor, Fraley had to travel to Tampa to receive treatments at the Moffitt Cancer Center.

Cancer centers, analytics, pharma plan precision medicine
Science & Enterprise – April 7
The coalition includes cancer centers in the Orien network — short for Oncology Research Information Exchange Network — with bioinformatics company M2Gen, and the pharmaceutical company Celgene that aims to generate many more cancer patients screened for clinical trials.

Cut for a Cure
WTSP – April 7
Cigar City took home the golden clippers for the most money raised. Funds will go to support research at hospitals across the country including Moffitt Cancer Center in Tampa.

Routine Imaging Not Necessary for HPV-Associated Oropharynx Cancer
OncLive – April 6
Treatment and follow-up for HPV-associated oropharynx cancer should differ from the standard of care for non–HPV-associated disease, explains Jessica Frakes, MD, an assistant member in the Department of Radiation Oncology at Moffitt Cancer Center. However, she adds, the NCCN currently does not truly distinguish between the 2 subsets.

Certain oncology agents enhance immunotherapy response in lung cancer mouse models
Immuno-Oncology News – April 5
Researchers at Moffitt Cancer Center in Tampa, Florida, screened 97 FDA-approved oncology agents with the ability to enhance T-cell chemokine expression — chemical messengers that stimulate T-cell infiltration into tumors to identify agents that could enhance immunotherapeutic responses.

NCCN Adds New Gene Mutations to Consider in Women's Cancers
Medscape – April 4
The recent discovery that the genetic mutation PALB2 is associated with an aggressive form of breast cancer, as well as the realization that the newer ovarian cancer genes RAD51C,RAD51D, and BRIP1 pose an added lifetime risk for ovarian cancer, should prompt physicians to discuss possible prophylactic procedures with patients who are found to carry these mutations, Tuya Pal, MD, from the Moffitt Cancer Center, Tampa, Florida, said here at the NCCN 21st Annual Conference

Histone deacetylase inhibitors enhance immunotherapy in lung cancer models, say Moffitt researchers
EScience News – April 4
Moffitt Cancer Center researchers have identified a class of drugs that improve the activity of immunotherapeutic antibodies by stimulating the movement of T cells into a tumor and enhancing their activity. 

VIDEO: Clinical differences can help identify adnexal primary vs. metastatic carcinoma
Helio – April 4
Jane L. Messina, MD, an anatomic pathologist of the Melanoma Research Center of Excellence at Moffitt Cancer Center, discussed the issues associated with distinguishing between adnexal primary carcinoma and metastatic melanoma at HemOnc Today Melanoma and Cutaneous Malignancies.

New CEO starts at Englewood Community Hospital
Englewood Sun – April 2
Powell-Stafford has been in health care management for more than 19 years, including executive positions with Yale New Haven Hospital and the H. Lee Moffitt Cancer Center prior to joining HCA in 2008.

NCCN Foundation Awards Grants to Five Young Investigators
Financial Buzz – April 1
The NCCN Foundation Has Awarded Its Sixth Series of Young Investigator Awards to Five Oncology Researchers From NCCN Member Institutions; the Awards Provide Grants of $150,000 Over a Two-Year Period for Research Initiatives Focused on Assessing and Improving Outcomes in Cancer Care. Moffitt Cancer Center was a recipient.

Experts say research shows promise for a breast cancer vaccine
Tampa Bay Times – March 31
Researchers have been studying cancer vaccines for decades, said Dr. Hatem Soliman, an assistant member in the breast cancer and immunology department at Moffitt Cancer Center in Tampa.


Please note we cannot guarantee the accuracy or availability of links. The stories belong to the respective publishers, and links may expire. Some news sites require you to register and select a password in order to retrieve articles, but most usually do not charge a fee to retrieve these news stories.